Conversely, a high level of PPARγ in mouse liver resulted in exacerbated hepatic steatosis through activating lipogenic genes, thereby increasing de novo lipogenesis and hepatic triglyceride content (Yu et al., 2003). This evidence concerns the gene PPARG and fatty liver disease.